Northpond Ventures — 2021 Investments
10 investments dated 2021 · listed companies and verified rows first · show all
Culture Biosciences provides software and bioreactor hardware solutions for bioprocess development, enabling researchers to design, monitor, and analyze experiments remotely with cloud-native analytics and AI/ML insights.
AI & Machine LearningBiotechCloud ComputingHealthtechSan Francisco, US
Will Patrick(Founder/CEO)inMatt Ball(Founder/CTO)in
Co-investorsCompoundDCVC (Data Collective)GRIDS CapitalHemisphere Ventures LLCThe E14 FundY Combinator+4 more
Current Health builds FDA-cleared clinical technology and infrastructure that enables acute and complex care—including advanced therapies like CAR-T, bispecifics, and cell and gene therapies—to be delivered safely in ambulatory and home settings.
AI & Machine LearningDigital HealthHealthtechMedical DevicesEdinburgh, US
Christopher McGhee(Founder)in
Co-investorsLRVHealthMMC VenturesOSF VenturesSection 32
San Diego protein-sequencing company behind the ProteoCode platform; ceased operations in late 2025.
Co-investorsARCH Venture PartnersDecheng CapitalAlexandriaDeerfield Management CompanyGV (Google Ventures)Nan Fung Life Sciences
Kytopen develops non-viral gene delivery technology called Flowfect that combines fluid flow with electric fields to deliver payloads such as mRNA, DNA, and CRISPR Cas9 RNP into cells for high-throughput transfection.
BiotechDeep TechHardwareCambridge, US
Cullen Buie(Director)inPaulo Garcia(Executive Officer, Director, Promoter)inMichael Chiu(Director, Executive Officer)in
BoardPaxton Major(Director)inAnn DeWitt(Director)inPaul Wotton(Director)
Co-investorsBantam GroupHorizons VenturesMassVenturesSelvedge VentureTBD AngelsTelegraph Hill Partners+2 more
Outcomes4Me is an AI-driven patient platform that integrates with NCCN clinical oncology guidelines to provide personalized cancer care guidance, treatment options, clinical trial recommendations, and genetic testing information.
AI & Machine LearningDigital HealthHealthtechCambridge, US
Maya R. Said(Founder and CEO)inOsama Rahma(Founder)in
BoardAndrea Jackson(Director)inDavid Fleshman(Director)David Auckland(Director)
Co-investorsAsset Management CompanyHealthX VenturesSierra VenturesAsset Management Ventures
Scitara provides cloud-based integration and data management software for scientific laboratories, enabling connection of lab instruments and applications into a unified environment with AI-powered analytics.
AI & Machine LearningBiotechData & InfrastructureSaaSMarlborough, US
Ajit Nagral(CEO & Chairman)inGeoff Gerhardt(Executive Officer, Promoter)inVinayak Purohit(Executive Officer)in
BoardCharles M. Hazard, Jr.(Director)Andrea Jackson(Director)inRohit Khanna(Director)
Co-investorsFlybridge Capital Partners
SimBioSys builds AI-powered 3D visualization and diagnostic technology that models tumors as "digital twins" to support individualized cancer treatment planning.
AI & Machine LearningBiotechDigital HealthMedical DevicesChicago, US
Joe Peterson(Co-founder)John Cole(Co-founder)Tushar Pandey(Co-founder)inStacey Stevens(Executive Officer, Director)in
BoardVikram Chaudhery(Director)inLucy Coassin(Director)
Co-investorsAV8 VenturesGenoa VenturesGENERAL INCEPTION
Palo Alto, US
Jonathan Hirsch(Executive Officer, Director)Glenn Winokur(Executive Officer, Director)Tony Loeser(Executive Officer)
BoardJohn Kuelper(Director)inChamath Palihapitiya(Director)Gary Kurtzman, M.D.(Director)
Co-investorsAscension VenturesSocial Capital Partnership
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Hawthorne Effect
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.